Cardinal Health 2011 Annual Report Download - page 40

I
tem
3
:Lega
l
Procee
d
ing
s
We become involved from time-to-time in litigation and regulatory matters incidental to our business,
i
nc
l
u
di
ng governmenta
li
nvest
i
gat
i
ons, en
f
orcement act
i
ons, persona
li
n
j
ury c
l
a
i
ms, emp
l
oyment matters
,
commercial disputes, intellectual propert
y
matters, disputes re
g
ardin
g
environmental clean-up costs, liti
g
ation in
connection with acquisitions and divestitures, and other matters arising out of the normal conduct of ou
r
b
us
i
ness. We
i
nten
d
to v
i
gorous
l
y
d
e
f
en
d
ourse
l
ves
i
n suc
hli
t
i
gat
i
on. We
d
o not
b
e
li
eve t
h
at t
h
e outcome o
f
any
pendin
g
liti
g
ation will have a material adverse effect on our consolidated financial statements.
I
tem
4
:Remove
d
an
d
Reserve
d
Execut
i
ve
Offi
cers o
f
the Re
gi
strant
T
he following is a list of our executive officers as of August 18, 2011:
N
ame Ag
e
P
osition
George S. Barrett
.
..........
5
6
C
hairman and Chief Executive Officer
J
e
ff
rey W. Hen
d
erso
n
........ 4
6
Chi
e
f
F
i
nanc
i
a
l Offi
cer
Michael C. Kaufman
n
........
48
C
hief Executive Officer, Pharmaceutical se
g
ment
Michael A. Lync
h
.
..........
5
0
C
hief Executive Officer, Medical segmen
t
C
ra
i
g S. Mor
f
or
d
............
52
Chi
e
f
Lega
l
an
d
Comp
li
ance O
ffi
cer
C
arole S. Watkin
s
.
..........
51
C
hief Human Resources Officer
Mark R. Blak
e
.
............. 40 Executive Vice President, Strategy and Corporate Developmen
t
Step
h
en T. Fa
lk
............. 4
6
Execut
i
ve V
i
ce Pres
id
ent, Genera
l
Counse
l
an
d
Corporate Secretary
T
he business experience summaries provided below for our executive officers describe positions held during
t
h
e
l
ast
fi
ve years (un
l
ess ot
h
erw
i
se
i
n
di
cate
d
).
Mr. Barrett has served as Chairman and Chief Executive Officer since August 2009. From January 2008 t
o
August 2009,
h
e serve
d
as V
i
ce C
h
a
i
rman o
f
Car
di
na
l
Hea
l
t
h
an
d
C
hi
e
f
Execut
i
ve O
ffi
cer, Hea
l
t
h
care Supp
ly
C
hain Services. From 1999 until 2007, he held a number of executive
p
ositions with Teva Pharmaceutica
l
I
ndustries Limited, a generic and branded pharmaceutical manufacturer, including President and Chief Executive
O
ffi
cer o
f
Teva Nort
h
Amer
i
ca, Corporate Execut
i
ve V
i
ce Pres
id
ent—G
l
o
b
a
l
P
h
armaceut
i
ca
l
Mar
k
ets an
da
member of the Office of the Chief Executive Officer, and President of Teva Pharmaceuticals USA
.
Mr. Henderson has served as Chief Financial Officer since May 2005.
Mr. Kaufmann has served as Chief Executive Officer, Pharmaceutical segment, since August 2009. From
Apr
il
2008 unt
il
August 2009,
h
e serve
d
as Group Pres
id
ent, P
h
armaceut
i
ca
l
Supp
l
yC
h
a
i
n,
f
rom Apr
il
2007 to
April 2008, he was Group President of Healthcare Suppl
y
Chain Services Medical se
g
ment, and from Septembe
r
200
5
to April 2007, he was Chief Financial Officer of Healthcare Supply Chain Services
.
Mr. L
y
nch has served as Chief Executive Officer, Medical se
g
ment, since Au
g
ust 2009. From Septembe
r
2008 until August 2009, he served as Group President, Medical and from July 2004 to September 2008, he wa
s
Group Pres
id
ent, Me
di
ca
l
Pro
d
ucts an
d
Tec
h
no
l
og
i
es.
Mr. Morford has served as Chief Legal and Compliance Officer since May 2009. From May 2008 to Ma
y
2009,
h
e serve
d
as C
hi
e
f
Comp
li
ance O
ffi
cer. From August 2007 to Marc
h
2008,
h
e was t
h
e Act
i
ng Deput
y
Attorne
y
General of the United States, from October 2006 to Jul
y
2007, he was United States Attorne
y
in
Nashville, Tennessee, and from March 200
5
to October 2006, he was First Assistant United States Attorney in
t
h
eUn
i
te
d
States Attorney’s o
ffi
ce
i
nC
l
eve
l
an
d
,O
hi
o
.
Ms. Watkins has served as Chief Human Resources Officer since 2000
.
14